A Comprehensive Evaluation of GeneLEAD VIII DNA Platform Combined to Deeplex Myc-TB® Assay to Detect in 8 Days Drug Resistance to 13 Antituberculous Drugs and Transmission of Mycobacterium tuberculosis Complex Directly From Clinical Samples

A Comprehensive Evaluation of GeneLEAD VIII DNA Platform Combined to Deeplex Myc-TB® Assay to Detect in 8 Days Drug Resistance to 13 Antituberculous Drugs and Transmission of Mycobacterium tuberculosis Complex Directly From Clinical Samples

The GeneLEAD VIII (Diagenode, Belgium) is a new, fully automated, sample-to-result precision instrument for the extraction of DNA and PCR detection of Mycobacterium tuberculosis complex (MTBC) directly from clinical samples. The Deeplex Myc-TB® assay (Genoscreen, France) is a diagnostic kit based on...

Full description

Bibliographic Details
Main Authors: Isabelle Bonnet, Vincent Enouf, Florence Morel, Vichita Ok, Jérémy Jaffré, Vincent Jarlier, Alexandra Aubry, Jérôme Robert, Wladimir Sougakoff
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-10-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
GeneLEAD VIII
Deeplex Myc-TB
Mycobacterium tuberculosis
diagnostic
resistance
spoligotype
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2021.707244/full

Internet

https://www.frontiersin.org/articles/10.3389/fcimb.2021.707244/full

Similar Items